SIRT3: A potential therapeutic target for liver fibrosis.
Ning Y, Dou X, Wang Z, Shi K, Wang Z, Ding C, Sang X, Zhong X, Shao M, Han X, Cao G.
Ning Y, et al. Among authors: ding c.
Pharmacol Ther. 2024 May;257:108639. doi: 10.1016/j.pharmthera.2024.108639. Epub 2024 Mar 30.
Pharmacol Ther. 2024.
PMID: 38561088
Review.